M Victoria Salgado, Pianpian Cao, Jihyoun Jeon, Luz M Sanchez-Romero, Theodore R Holford, David T Levy, Jamie Tam, Raul Mejia, Rafael Meza
{"title":"Modeling the impact of smoking on mortality in Argentina from 2000 to 2100. A Maximum Potential Reduction in Premature Mortality analysis.","authors":"M Victoria Salgado, Pianpian Cao, Jihyoun Jeon, Luz M Sanchez-Romero, Theodore R Holford, David T Levy, Jamie Tam, Raul Mejia, Rafael Meza","doi":"10.1093/ntr/ntaf117","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In Argentina, 23% of adults smoke; the future burden of smoking on mortality in the country is unknown. We estimate future smoking-attributable mortality if current smoking trends continue and compare this with an ideal scenario in which all smoking ceases in 2024.</p><p><strong>Methods: </strong>We developed a discrete deterministic compartmental simulation model of cigarette smoking by birth cohort in Argentina. The model was validated against observed sex-specific adult smoking prevalence. We then simulated smoking prevalence, smoking-attributable deaths (SADs), and life-years lost (LYL) from 2000 to 2100 under a Status Quo scenario, where future smoking prevalence follows current trends. Additionally, we modeled an ideal scenario where all smoking ceases starting in 2024. We calculated the Maximum Potential Reduction in Premature Mortality (MPRPM) as the LYL difference between the two scenarios from 2024 to 2100.</p><p><strong>Results: </strong>The model adequately reproduces observed smoking prevalence in Argentina. Approximately 55,700 SADs are estimated to occur in 2024. Under the Status Quo, over 4 million deaths due to smoking and around 79 million LYL would occur from 2000 to 2100. If all smoking had ceased in 2024, 49 million LYL due to smoking would still occur, resulting in an MPRPM of 30 million years, about 38% of the expected burden.</p><p><strong>Conclusion: </strong>Argentina faces a significant smoking-attributable mortality burden this century, with a substantial portion already unavoidable due to past smoking. Further tobacco control interventions, however, could still considerably reduce premature deaths and years of life lost. Prompt action is needed to realize these potential health gains.</p><p><strong>Implications: </strong>This modeling study provides an estimation of the future burden of smoking-attributable mortality in Argentina and highlights the maximum potential health benefits if all smoking would cease by 2024. While a portion of smoking-related mortality is unavoidable due to past smoking, the results show that further tobacco control interventions could still prevent a substantial number of premature deaths and life-years lost. These findings underscore the need for continued public health efforts to reduce smoking rates and mitigate its long-term effects on population health.</p>","PeriodicalId":19241,"journal":{"name":"Nicotine & Tobacco Research","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nicotine & Tobacco Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ntr/ntaf117","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: In Argentina, 23% of adults smoke; the future burden of smoking on mortality in the country is unknown. We estimate future smoking-attributable mortality if current smoking trends continue and compare this with an ideal scenario in which all smoking ceases in 2024.
Methods: We developed a discrete deterministic compartmental simulation model of cigarette smoking by birth cohort in Argentina. The model was validated against observed sex-specific adult smoking prevalence. We then simulated smoking prevalence, smoking-attributable deaths (SADs), and life-years lost (LYL) from 2000 to 2100 under a Status Quo scenario, where future smoking prevalence follows current trends. Additionally, we modeled an ideal scenario where all smoking ceases starting in 2024. We calculated the Maximum Potential Reduction in Premature Mortality (MPRPM) as the LYL difference between the two scenarios from 2024 to 2100.
Results: The model adequately reproduces observed smoking prevalence in Argentina. Approximately 55,700 SADs are estimated to occur in 2024. Under the Status Quo, over 4 million deaths due to smoking and around 79 million LYL would occur from 2000 to 2100. If all smoking had ceased in 2024, 49 million LYL due to smoking would still occur, resulting in an MPRPM of 30 million years, about 38% of the expected burden.
Conclusion: Argentina faces a significant smoking-attributable mortality burden this century, with a substantial portion already unavoidable due to past smoking. Further tobacco control interventions, however, could still considerably reduce premature deaths and years of life lost. Prompt action is needed to realize these potential health gains.
Implications: This modeling study provides an estimation of the future burden of smoking-attributable mortality in Argentina and highlights the maximum potential health benefits if all smoking would cease by 2024. While a portion of smoking-related mortality is unavoidable due to past smoking, the results show that further tobacco control interventions could still prevent a substantial number of premature deaths and life-years lost. These findings underscore the need for continued public health efforts to reduce smoking rates and mitigate its long-term effects on population health.
期刊介绍:
Nicotine & Tobacco Research is one of the world''s few peer-reviewed journals devoted exclusively to the study of nicotine and tobacco.
It aims to provide a forum for empirical findings, critical reviews, and conceptual papers on the many aspects of nicotine and tobacco, including research from the biobehavioral, neurobiological, molecular biologic, epidemiological, prevention, and treatment arenas.
Along with manuscripts from each of the areas mentioned above, the editors encourage submissions that are integrative in nature and that cross traditional disciplinary boundaries.
The journal is sponsored by the Society for Research on Nicotine and Tobacco (SRNT). It publishes twelve times a year.